We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PLX market cap is 84.01M. The company's latest EPS is USD 0.1138 and P/E is 10.02.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14.18M | 8.62M | 9.59M | 35.08M | 10.35M |
| Operating Income | -3.13M | -2.5M | -2.46M | 20.42M | -1.89M |
| Net Income | -3.57M | -3.74M | -3.13M | 19.34M | -1.85M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 54.69M | 62.9M | 38.35M | 47.64M | 65.49M |
| Operating Income | -10.72M | 2.71M | -20.46M | -13.01M | 10.46M |
| Net Income | -18.28M | -6.52M | -27.58M | -14.93M | 8.31M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 56.71M | 55.79M | 66.56M | 88.42M | 87.57M |
| Total Liabilities | 68.22M | 66.43M | 65.55M | 49.42M | 49.32M |
| Total Equity | -11.51M | -10.64M | 1.01M | 39M | 38.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 45.39M | 67.93M | 73.67M | 55.79M | 84.43M |
| Total Liabilities | 115.71M | 94.97M | 79.7M | 66.43M | 50.87M |
| Total Equity | -70.32M | -27.04M | -6.04M | -10.64M | 33.57M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.39M | -25M | -3M | 1.98M | -4.91M |
| Investing | -9.99M | -5.04M | 4.73M | 4.51M | -16.37M |
| Financing | 4.16M | 8.24M | 14.23M | 24.67M | 24.67M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.36M | -26.11M | -10.29M | -25M | -1.32M |
| Investing | -883k | -19.95M | 18.92M | -5.04M | -16.71M |
| Financing | N/A | 46.47M | 12.08M | 8.24M | 24.67M |
| Market Cap | 84.01M |
| Price to Earnings Ratio | 10.02 |
| Price to Sales Ratio | 1.27 |
| Price to Cash Ratio | 3.52 |
| Price to Book Ratio | 2.48 |
| Dividend Yield | - |
| Shares Outstanding | 73.05M |
| Average Volume (1 week) | 261.55k |
| Average Volume (1 Month) | 322.52k |
| 52 Week Change | -54.18% |
| 52 Week High | 3.55 |
| 52 Week Low | 1.09 |
| Spread (Intraday) | 0.01 (0.88%) |
| Company Name | Protalix BioTherapeutics Inc |
| Address |
108 w. 13th street wilmington, delaware 19801 |
| Website | https://protalix.com |
| Industry | management services (8741) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
